tm logo
DYNTIMIC
CANCELLED BY OWNER

on 19 Jun 2024

Last Applicant/ Owned by

NOVARTIS AG

CH-4002 Basel

CH

Serial Number

2120629 filed on 12th Feb 2021

Registration Number

TMA1153313 registered on 23rd Nov 2022

Registration expiry Date

18th Aug 2030

Correspondent Address

1100-150 York StreetToronto

ONTARIO

CA

M5H3S5

DYNTIMIC

Trademark usage description

pharmaceutical preparations for the prevention and treatment of the central nervous system, namely, central nervous system infections, brain diseases, Read More

Classification Information


Class [005]
Pharmaceutical preparations for the prevention and treatment of the central nervous system, namely, central nervous system infections, brain diseases, central nervous system movement disorders, ocular motility disorders, spinal cord diseases; pharmaceutical preparations for the prevention and treatment of immunologic diseases, namely, autoimmune diseases, immunologic deficiency syndromes; pharmaceutical preparations for the prevention and treatment of cardiovascular diseases; pharmaceutical preparations for the prevention and treatment of diabetes; pharmaceutical preparations for the prevention and treatment of metabolic disorders, namely, diabetes, obesity, hyperlipidemia, insulin resistance, metabolic syndrome; anti inflammatories; pharmaceutical preparations for the prevention and treatment of disorders of the respiratory system; pharmaceutical preparations for the prevention and treatment of disorders of the musculo-skeletal system, namely, connective tissue diseases, bone diseases, spinal diseases, back pain, fractures, sprains, cartilage injuries; pharmaceutical preparations for the prevention and treatment of genitourinary diseases, namely, urological diseases, infertility, sexually transmitted diseases, inflammatory pelvic diseases; pharmaceutical preparations for use in dermatology, namely, dermatitis, skin pigmentation diseases, sexually transmitted diseases; pharmaceutical preparations for use in oncology; pharmaceutical preparations for use in hematology, namely for the treatment of blood disorders; pharmaceutical preparations for use in tissue and organ transplantation; pharmaceutical preparations for use in ophthalmology; pharmaceutical preparations for use in gastroenterology; pharmaceutical preparations for prevention and treatment of ocular disorders and diseases; anti-infectives, antibacterials, antivirals, antibiotics, systemic and topical antifungals.


Classification kind code

11

Mark Details


Serial Number

2120629

Mark Type

Trademark

Legal History


Show more

Action TakenStatus
Submitted for opposition 48
on 13th Jun 2022
Agent Changed
Submitted for opposition 22
on 03rd Jun 2022
Search Recorded
Submitted for opposition 20
on 03rd Jun 2022
Examiner's First Report
Submitted for opposition 223
on 03rd Jun 2022
Total Provisional Refusal
Submitted for opposition 256
on 16th May 2022
Notification of Possible Opposition Sent
Submitted for opposition 257
on 15th Jul 2021
Designation Notification - Madrid Protocol
Submitted for opposition 1
on 14th Jul 2021
Created
Submitted for opposition 31
on 14th Jul 2021
Formalized
Submitted for opposition 30
on 12th Feb 2021
Filed
Submitted for opposition 228
on 18th Aug 2020
International Registration